These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3795622

  • 1. Effect of alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), a new anti-inflammatory drug, on the established adjuvant arthritis in rats.
    Hidaka T, Hosoe K, Yamashita T, Watanabe K.
    Jpn J Pharmacol; 1986 Oct; 42(2):181-7. PubMed ID: 3795622
    [Abstract] [Full Text] [Related]

  • 2. Analgesic and anti-inflammatory activities in rats of alpha-(3,5-di-t-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), and its intestinal damage.
    Hidaka T, Hosoe K, Yamashita T, Watanabe K, Hiramatsu Y, Fujimura H.
    J Pharm Pharmacol; 1986 Oct; 38(10):748-53. PubMed ID: 2878995
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
    Hidaka T, Hosoe K, Ariki Y, Takeo K, Yamashita T, Katsumi I, Kondo H, Yamashita K, Watanabe K.
    Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
    [Abstract] [Full Text] [Related]

  • 4. The effect of alpha-(3,5-di-t-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), a new anti-inflammatory drug, on leucocyte migration in rat carrageenan pleurisy.
    Hidaka T, Hosoe K, Katsumi I, Yamashita T, Watanabe K.
    J Pharm Pharmacol; 1986 Mar; 38(3):244-7. PubMed ID: 2871169
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug.
    Hidaka T, Takeo K, Hosoe K, Katsumi I, Yamashita T, Watanabe K.
    Jpn J Pharmacol; 1985 Jul; 38(3):267-72. PubMed ID: 3932730
    [Abstract] [Full Text] [Related]

  • 6. Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat.
    Engelhardt G, Homma D, Schnitzler C.
    Inflamm Res; 1995 Dec; 44(12):548-55. PubMed ID: 8788236
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96). V. Effects of SA96 in combination with indomethacin or prednisolone on adjuvant arthritis in rats].
    Yamauchi H, Hayashi M, Kasamatsu S, Nakata K, Mibu H, Iso T.
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):243-8. PubMed ID: 3874126
    [Abstract] [Full Text] [Related]

  • 8. A quantitative one-dimensional magnetic resonance imaging technique in adjuvant arthritis: the assessment of disease progression and indomethacin efficacy.
    Borah B, Francis MD, Hovancik K, Boyce JT, Szeverenyi NM.
    J Rheumatol; 1995 May; 22(5):855-62. PubMed ID: 8587072
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human gamma-globulin and adjuvant arthritis in rats].
    Yamauchi H, Hayashi M, Kasamatsu S, Suda H, Nakata K, Sasano M, Iso T.
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):275-82. PubMed ID: 2408978
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis.
    Tsurumi K, Kokuba S, Okada K, Yanagihara M, Fujimura H.
    Arzneimittelforschung; 1986 Dec; 36(12):1810-7. PubMed ID: 3566842
    [Abstract] [Full Text] [Related]

  • 11. A comparison of clodronate and indomethacin in the treatment of adjuvant arthritis.
    Osterman T, Kippo K, Laurén L, Pasanen I, Hannuniemi R, Sellman R.
    Inflamm Res; 1997 Mar; 46(3):79-85. PubMed ID: 9098719
    [Abstract] [Full Text] [Related]

  • 12. Effects of indomethacin administration on bone turnover and bone mass in adjuvant-induced arthritis in rats.
    Aota S, Nakamura T, Suzuki K, Tanaka Y, Okazaki Y, Segawa Y, Miura M, Kikuchi S.
    Calcif Tissue Int; 1996 Nov; 59(5):385-91. PubMed ID: 8849406
    [Abstract] [Full Text] [Related]

  • 13. The effect of treatment with recombinant gamma-interferon on adjuvant-induced arthritis in rats.
    Nakajima H, Takamori H, Hiyama Y, Tsukada W.
    Agents Actions; 1991 Sep; 34(1-2):63-5. PubMed ID: 1793053
    [Abstract] [Full Text] [Related]

  • 14. Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats.
    Bendele AM, McComb J, Gould T, Frazier J, Chlipala ES, Seely J, Kieft G, Wolf J, Edwards CK.
    Inflamm Res; 1999 Aug; 48(8):453-60. PubMed ID: 10493163
    [Abstract] [Full Text] [Related]

  • 15. Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis.
    Theisen-Popp P, Müller-Peddinghaus R.
    Agents Actions; 1994 Aug; 42(1-2):50-5. PubMed ID: 7847184
    [Abstract] [Full Text] [Related]

  • 16. Relationship of blood markers to disease severity and drug efficacy in rat adjuvant arthritis.
    Doughty JR, Goldberg RL, Schenkelaars EJ, Singh HN, Peppard J, Haston W, Blancuzzi VJ, Di Pasquale G.
    Agents Actions; 1991 Sep; 34(1-2):129-31. PubMed ID: 1793016
    [Abstract] [Full Text] [Related]

  • 17. Proteins of rat serum V: adjuvant arthritis and its modulation by nonsteroidal anti-inflammatory drugs.
    Ebrini I, Agnello D, Miller I, Villa P, Fratelli M, Ghezzi P, Gemeiner M, Chan J, Aebersold R, Gianazza E.
    Electrophoresis; 2000 Jun; 21(11):2170-9. PubMed ID: 10892728
    [Abstract] [Full Text] [Related]

  • 18. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage.
    Weichman BM, Chau TT, Rona G.
    Arthritis Rheum; 1987 Apr; 30(4):466-70. PubMed ID: 2953342
    [Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory activity of green versus black tea aqueous extract in a rat model of human rheumatoid arthritis.
    Ramadan G, El-Beih NM, Talaat RM, Abd El-Ghffar EA.
    Int J Rheum Dis; 2017 Feb; 20(2):203-213. PubMed ID: 25964045
    [Abstract] [Full Text] [Related]

  • 20. [Comparative characteristics of the anti-inflammatory and analgesic effects of voltaren, indomethacin and benzofurocaine in adjuvant disease in rats].
    Stepaniuk GI, Stoliarchuk AA, Lutsiuk NB, Smirnova OV, Cherviak MN.
    Patol Fiziol Eksp Ter; 1986 Feb; (5):78-82. PubMed ID: 3491973
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.